NRx Pharmaceuticals, Inc.
- NRXP
- NASDAQ
- Biotechnology
- CNS/Lung Disease Drugs
- Clinical-Stage Biotech
$2.60
Today −4.06%Quote Oct 16, 2026, 08:00 PM UTC
−23.30%over the last month
Max drawdown −23.6%From 1-month high −23.3%3 months −37.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$112.6M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$2.00
−23.1% from here
Floor
$2.58
0.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NRXPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
29